The gem index continues to fallFirstdepositbonuscasino, fell more than 1%, the number of stocks in the two markets fell to 4250, of which more than 600 stocks fell by more than 3%. The gap in the gem index has been filled, but there is still a gap below it near the 10,120 lines, between 1826 and 1831 points. The current level is 1869, and there is still about 2 per cent room to fall. Compared with Hong Kong stocks, the performance of A shares is relatively weak, with the Hang Seng Index up about 15% and the gem Index up about 4% since April 19.Firstdepositbonuscasino.5%, while the Shanghai Composite Index rose only 1.97%.

Funds continued to flow to biology-related areas, with strong performance in concept stocks such as cell therapy, immunotherapy and recombinant proteins. There are differences in the field of synthetic biology, and the performance of individual stocks is obviously differentiated. Musk's self-driving plan is making good progress, and China is likely to support Tesla in conducting self-driving tests at home. Smart cockpit and taxi plate changes obviously, Hua an Xinchuang (intelligent cockpit) and mass transit (600611) (taxi) and other stocks rose by the daily limit. Guangting Information and Fulin Transportation Industry (002357) and other stocks have a good morphological structure, which is worthy of attention.

firstdepositbonuscasino| Differences arise in the field of synthetic biology, and individual stocks are clearly divided

Plate name immunotherapy, recombinant protein, biological products keywords gem index, Hong Kong stock, Shanghai stock index bearish (neutral) A-share trend is relatively weak, compared with the Hong Kong stock market has a limited increase in this old standard, but also can absorb the risk tips of Hexun self-selected stock writers: the above content only serves as the views of the author or guests, does not represent any position of Hexun, and does not constitute any investment suggestions related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.